Clearside Biomedical Inc (CLSD) Insider Trading
- $5,983,394.60
- $10,253,417.17
- Nov. 1, 2024
- Clay Thorp
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Dec. 5, 2017 | Director | 15,000 | $6.37 | Sell | $95,550.00 | |
| Nov. 16, 2017 | Director | 35,000 | $7.00 | Sell | $245,000.00 | |
| Nov. 14, 2017 | Director | 15,000 | $7.02 | Sell | $105,300.00 | |
| Oct. 19, 2017 | Insider | 8,000 | $7.82 | Sell | $62,560.00 | |
| Oct. 5, 2017 | Director | 35,000 | $8.57 | Sell | $299,950.00 | |
| Sept. 15, 2017 | Director | 24,500 | $7.52 | Sell | $184,240.00 | |
| Sept. 14, 2017 | Director | 6,000 | $7.52 | Sell | $45,120.00 | |
| Sept. 13, 2017 | Director | 8,500 | $7.49 | Sell | $63,665.00 | |
| Sept. 8, 2017 | Insider | 16,000 | $7.57 | Sell | $121,120.00 | |
| Aug. 15, 2017 | Director | 1,100 | $7.00 | Buy | $7,700.00 | |
| Aug. 14, 2017 | CFO | 1,000 | $7.07 | Buy | $7,070.00 | |
| Aug. 11, 2017 | Director | 5,000 | $7.08 | Buy | $35,400.00 | |
| Aug. 9, 2017 | Director | 24,500 | $7.57 | Sell | $185,465.00 | |
| Aug. 8, 2017 | Director | 5,000 | $7.98 | Sell | $39,900.00 | |
| Aug. 7, 2017 | Director | 4,500 | $8.02 | Sell | $36,090.00 | |
| July 20, 2017 | Insider | 8,000 | $9.75 | Sell | $78,000.00 | |
| July 19, 2017 | CEO | 3,600 | $9.79 | Sell | $35,244.00 | |
| June 14, 2017 | Insider | 8,000 | $7.89 | Sell | $63,120.00 | |
| June 13, 2017 | CEO | 3,600 | $7.78 | Sell | $28,008.00 | |
| May 22, 2017 | Director | 1,100 | $8.00 | Buy | $8,800.00 | |
| May 19, 2017 | Director | 24,000 | $8.36 | Sell | $200,640.00 | |
| May 18, 2017 | Insider | 8,000 | $8.41 | Sell | $67,280.00 | |
| May 17, 2017 | Director | 44,485 | $8.63 | Sell | $383,905.55 | |
| May 16, 2017 | Director | 9,544 | $8.61 | Sell | $82,173.84 | |
| May 15, 2017 | Director | 15,941 | $8.94 | Sell | $142,512.54 | |
| April 19, 2017 | Director | 68,485 | $7.46 | Sell | $510,898.10 | |
| April 18, 2017 | Director | 44,455 | $7.48 | Sell | $332,523.40 | |
| April 17, 2017 | Director | 22,000 | $7.43 | Sell | $163,460.00 | |
| April 4, 2017 | Insider | 8,000 | $7.55 | Sell | $60,400.00 | |
| April 3, 2017 | CEO | 3,600 | $7.56 | Sell | $27,216.00 | |
| March 20, 2017 | Director | 2,200 | $6.90 | Buy | $15,180.00 | |
| March 16, 2017 | Director | 68,485 | $6.56 | Sell | $449,261.60 | |
| Feb. 22, 2017 | Director | 27,000 | $7.55 | Sell | $203,850.00 | |
| Feb. 17, 2017 | Director | 41,485 | $7.60 | Sell | $315,286.00 | |
| Jan. 20, 2017 | Director | 68,485 | $8.53 | Sell | $584,177.05 | |
| Jan. 19, 2017 | Insider | 25,301 | $8.63 | Sell | $218,347.63 | |
| June 7, 2016 | Major Shareholder | 414,286 | $7.00 | Buy | $2,900,002.00 | |
| June 7, 2016 | Director | 138 | $7.00 | Sell | $966.00 |
Insiders are both buying and selling Clearside Biomedical Inc stock.
The insider traders at Clearside Biomedical Inc are: Clay Thorp, Daniel H White, Bradford T Whitmore, George M Lasezkay, Charles A Deignan, Thomas Ciulla, Christy L Shaffer, Nancy J Hutson, Ngai Hang Victor Chong, Gerald D Cagle, William D Humphries, Benjamin R Yerxa, Bradford T. Whitmore, George M. Lasezkay, Venture Advisors Iii Hatteras, Venture Advisors Iv S Hatteras, and Anthony S Gibney
The most active insider trader at Clearside Biomedical Inc is Clay Thorp with 28 trades.
Clay Thorp has sold the most Clearside Biomedical Inc stock with a total value of $7,099,536.98.
Venture Advisors Iv S Hatteras has bought the most Clearside Biomedical Inc stock with a total value of $5,800,004.00.
The most recent insider trade for Clearside Biomedical Inc was on Nov. 1, 2024.
The single biggest insider buy for Clearside Biomedical Inc was from Venture Advisors Iv S Hatteras with a total value of $2,900,002.00 on June 7, 2016.
The single biggest insider sell for Clearside Biomedical Inc was from Clay Thorp with a total value of $2,107,698.12 on May 18, 2018.